Imaginostics

United States
Orlando, Florida, United States, 32827

Company profile

Imaginostics company profile

Imaginostics is creating the next generation of precision medicine diagnostic and prognostic tools to serve clinicians and drug developers to transform personalized healthcare, accelerate drug development, and fight aging. Our proprietary MRI physics-based technology delivers 10X better vascular images and quantitative measurements for vascular structure, function, and leakage. Our technology and software are compatible with existing MRI scanners, and as a bonus, is compatible with safe iron supplement for contrast (not toxic gadolinium). We provide biomarker solutions through CROs to pharma and participate in pre-clinical and clinical research in a variety of focus areas collaborating with world-renowned researchers at leading institutions. To learn more, please visit: http://www.imaginostics.com

Business identity

Contact email
[email protected]
Phone number
833-674-7226
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2018-07-10

Headquarters

Postal code
32827
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
7
Total equity funding
$7.1M
Last funding
Seed / $5.3M / 2024-06-01
Last equity funding
Seed / $5.3M
Investors
4
Lead investors
3
Founders
2

Founders and investors

Founders

Codi GharagouzlooValerie Gharagouzloo

Lead investors

Alzheimer's Drug Discovery FoundationNational Institute of Mental HealthNational Institute on Aging

Investors

Alzheimer's Drug Discovery FoundationIdeashipNational Institute of Mental HealthNational Institute on Aging